相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor suppressor p53 promotes ferroptosis in oxidative stress conditions independent of modulation of ferroptosis by p21, CDKs, RB, and E2F
Nishanth Kuganesan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Senolytics for Cancer Therapy: Is All that Glitters Really Gold?
Valerie J. Carpenter et al.
CANCERS (2021)
Protective role of cytoplasmic p21Cip1/Waf1 in apoptosis of CDK4/6 inhibitor-induced senescence in breast cancer cells
Irna D. Kartika et al.
CANCER MEDICINE (2021)
Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation
Andras Lanczky et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2021)
Pemetrexed sensitizes human lung cancer cells to cytotoxic immune cells
Tamio Okimoto et al.
CANCER SCIENCE (2020)
Ferroptosis at the crossroads of infection, aging and cancer
Shinya Toyokuni et al.
CANCER SCIENCE (2020)
Therapy-Induced Senescence: An Old Friend Becomes the Enemy
Tareq Saleh et al.
CANCERS (2020)
Senescence in the Development and Response to Cancer with Immunotherapy: A Double-Edged Sword
Anthony M. Battram et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
p21 can be a barrier to ferroptosis independent of p53
Divya Venkatesh et al.
Aging-US (2020)
Clearance of therapy-induced senescent tumor cells by the senolytic ABT-263 via interference with BCL-XL-BAX interaction
Tareq Saleh et al.
MOLECULAR ONCOLOGY (2020)
Targeting ferroptosis for cancer therapy: exploring novel strategies from its mechanisms and role in cancers
Minlin Jiang et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Senolytics and senostatics as adjuvant tumour therapy
Susan Short et al.
EBIOMEDICINE (2019)
Different sensitivities of senescent breast cancer cells to immune cell-mediated cytotoxicity
Touko Inao et al.
CANCER SCIENCE (2019)
Patterns of Early p21 Dynamics Determine Proliferation-Senescence Cell Fate after Chemotherapy
Chien-Hsiang Hsu et al.
CELL (2019)
p21Waf1/Cip1: its paradoxical effect in the regulation of breast cancer
Samir F. Zohny et al.
BREAST CANCER (2019)
The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy
Nina-Naomi Kreis et al.
CANCERS (2019)
Tumor cell escape from therapy-induced senescence
Tareq Saleh et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Cellular senescence: a promising strategy for cancer therapy
Seongju Lee et al.
BMB REPORTS (2019)
Mechanisms and functions of cellular senescence
Nicolas Herranz et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Two-Step Senescence-Focused Cancer Therapies
Cynthia J. Sieben et al.
TRENDS IN CELL BIOLOGY (2018)
Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer
Ryosuke Tanino et al.
Oncotarget (2018)
p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells
Amy Tarangelo et al.
CELL REPORTS (2018)
Unsolved mysteries: How does lipid peroxidation cause ferroptosis?
Huizhong Feng et al.
PLOS BIOLOGY (2018)
p21: A Two-Faced Genome Guardian
Alexandros G. Georgakilas et al.
TRENDS IN MOLECULAR MEDICINE (2017)
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al.
CELL (2017)
Is Senescence Reversible?
Shweta Chakradeo et al.
CURRENT DRUG TARGETS (2016)
Ferrootosis: Death by Lipid Peroxidation
Wan Seok Yang et al.
TRENDS IN CELL BIOLOGY (2016)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer (vol 8, e82241, 2013)
B. Gyoerffy et al.
PLOS ONE (2014)
Aging, Cellular Senescence, and Cancer
Judith Campisi
ANNUAL REVIEW OF PHYSIOLOGY, VOL 75 (2013)
CDKN2A/p16 Inactivation Mechanisms and Their Relationship to Smoke Exposure and Molecular Features in Non-Small-Cell Lung Cancer
Kit W. Tam et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
DNA damage checkpoints in stem cells, ageing and cancer
Tobias Sperka et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Protein and its Function Based on a Subcellular Localization
Jana Cmielova et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
Jean -Philippe Coppe et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
SOD1 and MitoTEMPO partially prevent mitochondrial permeability transition pore opening, necrosis, and mitochondrial apoptosis after ATP depletion recovery
Huan Ling Liang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
SENESCENCE Senescence in tumours: evidence from mice and humans
Manuel Collado et al.
NATURE REVIEWS CANCER (2010)
p21 in cancer: intricate networks and multiple activities
Tarek Abbas et al.
NATURE REVIEWS CANCER (2009)
ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse et al.
CANCER RESEARCH (2008)
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
Giorgio Vittorio Scagliotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy
N Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy
CA Schmitt et al.
CELL (2002)
Cellular senescence as a tumor-suppressor mechanism
J Campisi
TRENDS IN CELL BIOLOGY (2001)
分享论文
